Integra LifeSciences Holdings Missed Consensus Estimates

Integra LifeSciences Holdings (IART) reported earnings of $0.41 per share on revenue of $382.65 million for the first quarter ended March 2025. The consensus earnings estimate was $0.43 per share on revenue of $382.17 million. The company missed consensus estimates by 4.65% while revenue grew 3.74% on a year-over-year basis.

The company said it expects second quarter earnings of $0.40 to $0.45 per share on revenue of $390.0 million to $400.0 million and now expects 2025 earnings of $2.19 to $2.29 per share while continuing to expect revenue of $1.650 billion to $1.715 billion. The company's previous guidance was 2025 earnings of $2.41 to $2.51 per share. The current consensus estimate is earnings of $0.58 per share on revenue of $417.75 million for the quarter ending June 30, 2025 and earnings of $2.46 per share on revenue of $1.68 billion for the year ending December 31, 2025.

Integra Lifesciences Holdings Corp is engaged in the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments.